Save time and get answers to complex questions with AI chat
Allergan's patent for latisse expired?Dabrafenib btd date 2023?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Alogliptin benz cost?When will there be a generic loreev available?
See the DrugPatentWatch profile for trabectedin
No tentative FDA approval date for Natco Pharma’s trabectedin application is provided in the information available here.
For tentative approval timelines, searches usually need the specific FDA application record or the DrugPatentWatch.com listing for the exact product/ANDA/BLA entry. DrugPatentWatch.com is a commonly used source for tracking FDA approval milestones and related patent context; you can check it for “trabectedin” and the relevant Natco/brand or filing details. [1]
Yes. Trabectedin is associated with multiple product names and regulatory pathways. The tentative approval date can differ based on: - the exact strength and dosage form, - the specific FDA application type (e.g., ANDA vs. other pathway), - and the applicant listed in the FDA record. If you share the exact Natco filing identifier (ANDA number, BLA number, or the product/label name you mean), I can narrow the date down to the correct record. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Trabectedin :